Press release

RICHARD BERGSTRÖM APPOINTED DIRECTOR GENERAL OF

EFPIA
Brussels, 18 March: EFPIA, the European Federation of the Pharmaceutical Industries and Associations, today
announced that its new Director General will be Richard Bergström. Mr. Bergström, who will take up the position on 1
April 2011, is currently Director General of LIF, the Swedish research-based pharmaceutical industry association. He
succeeds Brian Ager, who will join the European Round Table of Industrialists as Secretary General.

Mr. Bergström, who is a pharmacist by training, has almost 20 years experience in the industry. A graduate of the
University of Uppsala, Sweden in 1988, he began his career in the Swedish Medical Products Agency. He subsequently
worked in senior positions in regulatory affairs for both Roche and Novartis in Switzerland before moving to LIF in
2002. He has been a member of the EFPIA Board for a number of years, and chairs its Trust Committee and its Task
Force on Health Technology Assessment. He is also a Council member of the International Federation of
Pharmaceutical Manufacturers Associations (IFPMA). He has served on several Swedish government commissions and
is currently Vice-Chairman of the board of the Karolinska Institutet.

Mr. Bergström said: “It is a great honour for me to accept this role at EFPIA. The research-based pharmaceutical
industry can make a major contribution in progressing some of Europe’s most important objectives, including improved
economic competitiveness, better healthcare for all citizens, and an ageing population that enjoys a high quality of life.”
He added; “In my professional life I have learnt to listen to governments and other stakeholders to make sure that my
industry meets the expectations of society. I will bring this modus operandi to EFPIA and look forward to forging new
partnerships to ensure that Europe’s patients benefit from the valuable innovation provided by our medicines and
vaccines. We must work with others in delivering sustainable, equitable healthcare for all”.

Andrew Witty, CEO of GlaxoSmithKline and President of EFPIA said: “We are delighted that Richard will be EFPIA’s
new Director General; his experience and approach are exactly what we need at this time. I am confident he will lead the
continued transformation of EFPIA into a valued partner to all its stakeholders”. He continued; “On behalf of the EFPIA
membership, I would also like to thank Brian Ager for his leadership and dedication over the last 16 years. We sincerely
wish him well in his new role.”

###

Contact Useful links

Colin Mackay, Tel: (+32) 2 626 25 57 www.efpia.eu

E-mail: colinmackay@efpia.org www.animalresearchforlife.eu

Leopold Plaza Building T +32 2 626 25 55

European Federation of Pharmaceutical
Rue du Trône 108 Boîte 1 F +32 2 626 25 66
Industries and Associations
B-1050 Bruxelles www.efpia.eu
About EFPIA
EFPIA represents the pharmaceutical industry operating in Europe. Through its direct membership of 31 national associations and
40 leading pharmaceutical companies, EFPIA provides the voice of 2,200 companies committed to researching, developing and
bringing new medicines to improve health and quality of life around the world.

EFPIA member are committed to delivering innovative medicines to address unmet needs of patients and reducing the burden of
chronic diseases for Europe’s ageing population. EFPIA believes in close cooperation with its stakeholders to help create sustainable
healthcare systems and to develop prompt responses to health threats in Europe.

The pharmaceutical sector directly employs some 635,000 people in Europe including 117,000 working in research and development.
The industry also generates around three to four times more employment both upstream and downstream.

Europe’s research-based pharmaceutical industry generates a substantial trade surplus, estimated at about €48,000 million in 2008,
and has contributed significantly to reducing the European Union’s trade deficit in high-tech products. Almost a quarter of the EU’s
high-tech exports are pharmaceutical products.

Fédération Européenne d’Associations et d’Industries Leopold Plaza Building T +32 2 626 25 55

Pharmaceutiques Rue du Trône 108 Boîte 1 F +32 2 626 25 66
B-1050 Bruxelles www.efpia.eu